Passa al contenuto
Merck
Tutte le immagini(1)

Documenti fondamentali

791056P

Avanti

2-OHOA

2-hydroxyoleic acid (sodium salt), powder

Sinonimo/i:

Minerval; NaCHOleate; 2OHOA

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali

Scegli un formato

1 G
CHF 205.00

CHF 205.00


Check Cart for Availability

Richiedi un ordine bulk

Scegli un formato

Cambia visualizzazione
1 G
CHF 205.00

About This Item

Formula empirica (notazione di Hill):
C18H33NaO3
Numero CAS:
Peso molecolare:
320.44
Numero MDL:
Codice UNSPSC:
12352211
NACRES:
NA.25

CHF 205.00


Check Cart for Availability

Richiedi un ordine bulk

Saggio

>99% (TLC)

Stato

powder

Confezionamento

pkg of 1 × 1 g (791056P-1g)

Produttore/marchio commerciale

Avanti Research - A Croda Brand 791056P

Tipo di lipide

neutral lipids
neutral glycerides

Condizioni di spedizione

dry ice

Temperatura di conservazione

−20°C

Descrizione generale

2-hydroxyoleic acid (2-OHOA) is a synthetic and non-β oxidation-metabolizable oleic acid derivative.[1] It contains 18 carbon atoms in its fatty acid chain length.[2]

Applicazioni

2-hydroxyoleic acid (2-OHOA) is suitable for use:
  • to study its antihypertensive action in adult spontaneously hypertensive rats (SHRs)[1]
  • to study the chemical structure-effect relation of 2-OHOA in the reduction of body weight in rats[2]
  • as an antitumor compound, to study its effect on xenografts lipidome based on imaging mass spectrometry (IMS)[3]

Azioni biochim/fisiol

2-Hydroxy Oleic Acid is an inducer of cell cycle arrest and apoptosis in several cancer cell lines, including glioma, leukemia, breast and colon cancer lines. 2-Hydroxy Oleic Acid increases sphingomyelin (SM) levels in the membranes of tumor cells, which typically display decreased SM membrane content, and remodeled membranes, compared with normal cells. The compound has no effect on SM levels in non-cancer cells.
2-hydroxyoleic acid (2-OHOA) acts as a potential antihypertensive agent.[4] Oral administration of 2-OHOA is used to reduce body weight.[2]

Confezionamento

20 mL Clear Glass Screw Cap Vial (791056P-1g)

Note legali

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Codice della classe di stoccaggio

11 - Combustible Solids


Scegli una delle versioni più recenti:

Certificati d'analisi (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documenti section.

Se ti serve aiuto, non esitare a contattarci Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Structure-effect relation of C18 long-chain fatty acids in the reduction of body weight in rats
Vogler O, et al.
International Journal of Obesity, 32(3), 464-464 (2008)
Victoria Llado et al.
Journal of cellular and molecular medicine, 14(3), 659-670 (2009-05-06)
Minerval is an oleic acid synthetic analogue that impairs lung cancer (A549) cell proliferation upon modulation of the plasma membrane lipid structure and subsequent regulation of protein kinase C localization and activity. However, this mechanism does not fully explain the
Alena Khmelinskaia et al.
Langmuir : the ACS journal of surfaces and colloids, 30(8), 2117-2128 (2014-02-05)
Recent research regarding 2-hydroxylated fatty acids (2OHFAs) showed clear evidence of their benefits in the treatment of cancer, inflammation, and neurodegenerative disorders such as Alzheimer's disease. Monolayer compressibility isotherms and isothermal titration calorimetry of 2OHFA (C18-C22) in phosphatidylcholine/phosphatidylethanolamine/sphingomyelin/cholesterol (1:1:1:1 mole
Victoria Lladó et al.
Biochimica et biophysica acta, 1838(6), 1619-1627 (2014-02-15)
This review summarizes the cellular bases of the effects of NaCHOleate (2-hydroxyoleic acid; 2OHOA; Minerval) against glioma and other types of tumors. NaCHOleate, activates sphingomyelin synthase (SGMS) increasing the levels of cell membrane sphingomyelin (SM) and diacylglycerol (DAG) together with
Silvia Terés et al.
Proceedings of the National Academy of Sciences of the United States of America, 109(22), 8489-8494 (2012-05-16)
Despite recent advances in the development of new cancer therapies, the treatment options for glioma remain limited, and the survival rate of patients has changed little over the past three decades. Here, we show that 2-hydroxyoleic acid (2OHOA) induces differentiation

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.